{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T04:24:55Z","timestamp":1785039895322,"version":"3.55.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T00:00:00Z","timestamp":1620777600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008676","name":"CMC Microsystems","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008676","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009947","name":"Merck Sharp and Dohme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002973","name":"Daiichi-Sankyo","doi-asserted-by":"publisher","award":["\u20ac10 000"],"award-info":[{"award-number":["\u20ac10 000"]}],"id":[{"id":"10.13039\/501100002973","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["esmoopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Open"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.esmoop.2021.100168","type":"journal-article","created":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T17:09:37Z","timestamp":1622826577000},"page":"100168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Primary tumor side is associated with prognosis of colorectal cancer patients with brain metastases"],"prefix":"10.1016","volume":"6","author":[{"given":"E.S.","family":"Bergen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Scherleitner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Kiesel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Widhalm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Dieckmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Prager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Preusser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.S.","family":"Berghoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.esmoop.2021.100168_bib1","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ijc.10635","article-title":"Are there two sides to colorectal cancer?","volume":"101","author":"Iacopetta","year":"2002","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.esmoop.2021.100168_bib2","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1152\/physiolgenomics.00185.2006","article-title":"Map of differential transcript expression in the normal human large intestine","volume":"33","author":"LaPointe","year":"2008","journal-title":"Physiol Genomics"},{"issue":"11","key":"10.1016\/j.esmoop.2021.100168_bib3","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1007\/s12094-019-02083-1","article-title":"Clinical characteristics and prognosis of different primary tumor location in colorectal cancer: a population-based cohort study","volume":"21","author":"Zheng","year":"2019","journal-title":"Clin Transl Oncol"},{"issue":"3","key":"10.1016\/j.esmoop.2021.100168_bib4","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000510944","article-title":"Molecular biomarkers according to primary tumor location in colorectal cancer: current standard and new insights","volume":"99","author":"De Renzi","year":"2021","journal-title":"Oncology"},{"issue":"2","key":"10.1016\/j.esmoop.2021.100168_bib5","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ejso.2010.12.004","article-title":"Colon carcinoma--classification into right and left sided cancer or according to colonic subsite?--Analysis of 29,568 patients","volume":"37","author":"Benedix","year":"2011","journal-title":"Eur J Surg Oncol"},{"issue":"10","key":"10.1016\/j.esmoop.2021.100168_bib6","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1093\/annonc\/mdu275","article-title":"Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical features","volume":"25","author":"Missiaglia","year":"2014","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.esmoop.2021.100168_bib7","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1080\/14737140.2018.1442217","article-title":"Difference between right-sided and left-sided colorectal cancers: from embryology to molecular subtype","volume":"18","author":"Yang","year":"2018","journal-title":"Expert Rev Anticancer Ther"},{"issue":"4","key":"10.1016\/j.esmoop.2021.100168_bib8","doi-asserted-by":"crossref","first-page":"264","DOI":"10.14740\/gr1062w","article-title":"Difference between left-sided and right-sided colorectal cancer: a\u00a0focused review of literature","volume":"11","author":"Baran","year":"2018","journal-title":"Gastroenterol Res"},{"key":"10.1016\/j.esmoop.2021.100168_bib9","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3389\/fmicb.2015.00020","article-title":"Microbiota disbiosis is associated with colorectal cancer","volume":"6","author":"Gao","year":"2015","journal-title":"Front Microbiol"},{"issue":"suppl 15","key":"10.1016\/j.esmoop.2021.100168_bib11","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1200\/JCO.2016.34.15_suppl.3504","article-title":"Impact of primary (1\u00b0) tumor location on overall survival (OS) and progression-free survival (PFS) in patients (pts) with metastatic colorectal cancer (mCRC): analysis of CALGB\/SWOG 80405 (Alliance)","volume":"34","author":"Venook","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"issue":"8","key":"10.1016\/j.esmoop.2021.100168_bib12","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1093\/annonc\/mdx119","article-title":"Primary tumor sidedness has an impact on prognosis and treatment outcome in metastatic colorectal cancer: results from two randomized first-line panitumumab studies","volume":"28","author":"Boeckx","year":"2017","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.esmoop.2021.100168_bib13","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jamaoncol.2016.3797","article-title":"Prognostic and predictive relevance of primary tumor location in patients with RAS wild-type metastatic colorectal cancer: retrospective analyses of the CRYSTAL and FIRE-3 trials","volume":"3","author":"Tejpar","year":"2017","journal-title":"JAMA Oncol"},{"issue":"8","key":"10.1016\/j.esmoop.2021.100168_bib14","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1093\/annonc\/mdx175","article-title":"Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials\u2020","volume":"28","author":"Arnold","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.esmoop.2021.100168_bib15","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejca.2016.10.007","article-title":"The relevance of primary tumour location in patients with metastatic colorectal cancer: a meta-analysis of first-line clinical trials","volume":"70","author":"Holch","year":"2017","journal-title":"Eur J Cancer"},{"issue":"33","key":"10.1016\/j.esmoop.2021.100168_bib16","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1200\/JCO.19.01254","article-title":"Negative hyperselection of patients with RAS and BRAF wild-type metastatic colorectal cancer who received panitumumab-based maintenance therapy","volume":"37","author":"Morano","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.esmoop.2021.100168_bib17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/DCR.0b013e3181c703a4","article-title":"Comparison of 17,641 patients with right- and left-sided colon cancer: differences in epidemiology, perioperative course, histology, and survival","volume":"53","author":"Benedix","year":"2010","journal-title":"Dis Colon Rectum"},{"issue":"22","key":"10.1016\/j.esmoop.2021.100168_bib18","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.3748\/wjg.v10.i22.3345","article-title":"Patients with brain metastases from gastrointestinal tract cancer treated with whole brain radiation therapy: prognostic factors and survival","volume":"10","author":"Bartelt","year":"2004","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.esmoop.2021.100168_bib19","first-page":"39","article-title":"Estimating survival in patients with gastrointestinal cancers and brain metastases: an update of the graded prognostic assessment for gastrointestinal cancers (GI-GPA)","volume":"18","author":"Sperduto","year":"2019","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.esmoop.2021.100168_bib20","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.trsl.2019.02.011","article-title":"Survival and prognostic factors in patients with gastrointestinal cancers and brain metastases: have we made progress?","volume":"208","author":"Sperduto","year":"2019","journal-title":"Transl Res"},{"issue":"4","key":"10.1016\/j.esmoop.2021.100168_bib21","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0895-4356(00)00314-0","article-title":"Adjusting for multiple testing--when and how?","volume":"54","author":"Bender","year":"2001","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"8","key":"10.1016\/j.esmoop.2021.100168_bib22","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/S1470-2045(14)70227-X","article-title":"Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial","volume":"15","author":"Taieb","year":"2014","journal-title":"Lancet Oncol"},{"issue":"15","key":"10.1016\/j.esmoop.2021.100168_bib23","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1200\/JCO.2017.76.0355","article-title":"Three versus 6 months of oxaliplatin-based adjuvant chemotherapy for patients with stage III colon cancer: disease-free survival results from a randomized, open-label, international duration evaluation of adjuvant (IDEA) France, phase III trial","volume":"36","author":"Andr\u00e9","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"issue":"8","key":"10.1016\/j.esmoop.2021.100168_bib24","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1007\/s11605-019-04308-8","article-title":"Colorectal cancer metastases to brain or bone and the relationship to primary tumor location: a population-based study","volume":"24","author":"Lei","year":"2020","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"8","key":"10.1016\/j.esmoop.2021.100168_bib25","first-page":"755","article-title":"Distinguishing right from left colon by the pattern of gene expression","volume":"12","author":"Glebov","year":"2003","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"49","key":"10.1016\/j.esmoop.2021.100168_bib26","doi-asserted-by":"crossref","first-page":"86356","DOI":"10.18632\/oncotarget.21169","article-title":"Comparative molecular analyses of left-sided colon, right-sided colon, and rectal cancers","volume":"8","author":"Salem","year":"2017","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/j.esmoop.2021.100168_bib27","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1038\/nm.3967","article-title":"The consensus molecular subtypes of colorectal cancer","volume":"21","author":"Guinney","year":"2015","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.esmoop.2021.100168_bib28","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1158\/1078-0432.CCR-17-2484","article-title":"Classifying colorectal cancer by tumor location rather than sidedness highlights a continuum in mutation profiles and consensus molecular subtypes","volume":"24","author":"Loree","year":"2018","journal-title":"Clin Cancer Res"},{"issue":"8","key":"10.1016\/j.esmoop.2021.100168_bib29","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1002\/cncr.29196","article-title":"RAS mutations affect pattern of metastatic spread and increase propensity for brain metastasis in colorectal cancer","volume":"121","author":"Yaeger","year":"2015","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.esmoop.2021.100168_bib30","doi-asserted-by":"crossref","first-page":"R46","DOI":"10.1186\/bcr2603","article-title":"HER3 and downstream pathways are involved in colonization of brain metastases from breast cancer","volume":"12","author":"Da Silva","year":"2010","journal-title":"Breast Cancer Res"},{"issue":"11","key":"10.1016\/j.esmoop.2021.100168_bib31","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1093\/neuonc\/noz105","article-title":"Targeting the PI3K\/Akt\/mTOR pathway with the pan-Akt inhibitor GDC-0068 in PIK3CA-mutant breast cancer brain metastases","volume":"21","author":"Ippen","year":"2019","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.esmoop.2021.100168_bib32","article-title":"Response of brain metastases from PIK3CA-mutant breast cancer to alpelisib","volume":"4","author":"Batalini","year":"2020","journal-title":"JCO Precis Oncol"},{"issue":"11","key":"10.1016\/j.esmoop.2021.100168_bib33","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1158\/1078-0432.CCR-18-3049","article-title":"The dual PI3K\/mTOR pathway inhibitor GDC-0084 achieves antitumor activity in PIK3CA-mutant breast cancer brain metastases","volume":"25","author":"Ippen","year":"2019","journal-title":"Clin Cancer Res"}],"container-title":["ESMO Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702921001289?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702921001289?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T20:27:56Z","timestamp":1761856076000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2059702921001289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S2059702921001289"],"URL":"https:\/\/doi.org\/10.1016\/j.esmoop.2021.100168","relation":{},"ISSN":["2059-7029"],"issn-type":[{"value":"2059-7029","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary tumor side is associated with prognosis of colorectal cancer patients with brain metastases","name":"articletitle","label":"Article Title"},{"value":"ESMO Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.esmoop.2021.100168","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100168"}}